Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
11/15/20122:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/15/20122:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/09/201210:07AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/09/201210:07AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/07/201211:39AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:IMGNImmunoGen Inc
11/07/20125:59AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:IMGNImmunoGen Inc
11/06/20125:06PMDow Jones NewsFDA Gives Priority Review to ImmunoGen, Roche Breast Cancer DrugNASDAQ:IMGNImmunoGen Inc
11/06/20123:30PMBusiness WireImmunoGen, Inc. Announces FDA Has Granted Priority Review Status to the Trastuzumab Emtansine (T-DM1) Marketing ApplicationNASDAQ:IMGNImmunoGen Inc
11/05/20122:15PMBusiness WireImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor ConferencesNASDAQ:IMGNImmunoGen Inc
11/05/20127:45AMMarketwiredFree Research Reports on CLF, IMGN, SVNT and TSYS Issued by the Bedford ReportNASDAQ:IMGNImmunoGen Inc
11/02/20127:20AMMarketwiredFDA Considering Allowing Developers of Critical Drugs/Treatments to Conduct Smaller, Faster Clinical TrialsNASDAQ:IMGNImmunoGen Inc
10/31/20129:16AMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:IMGNImmunoGen Inc
10/31/20129:16AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
10/31/20129:16AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
10/31/20129:16AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
10/31/20129:16AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
10/26/20125:40AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:IMGNImmunoGen Inc
10/26/20125:30AMBusiness WireImmunoGen, Inc. Reports First Quarter Fiscal Year 2013 Financial Results and Provides Quarterly UpdateNASDAQ:IMGNImmunoGen Inc
10/19/20125:30AMBusiness WireImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2013 Financial ResultsNASDAQ:IMGNImmunoGen Inc
10/18/201211:35AMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:IMGNImmunoGen Inc
10/17/201211:16AMZacksRoche's 9M Sales Climb - Analyst BlogNASDAQ:IMGNImmunoGen Inc
10/10/201212:41PMEdgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN